Showing results (1221-1230 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 24, 2001
Economic evaluation of a new acellular vaccine for pertussis in CanadaM Iskedjian, T R Einarson, B J O'Brien, et al.Pharmacoeconomics|July 24, 2001
Cost effectiveness of desirudin compared with a low molecular weight heparin in the prevention of deep vein thrombosis after total hip replacement surgeryL A Levin, D BergqvistPharmacoeconomics|July 24, 2001
The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF GroupL C Ballesteros, M I Fernández San Martín, T Sanz Cuesta, et al.Pharmacoeconomics|July 24, 2001
Cost effectiveness of selective decontamination of the digestive tract in liver transplant patientsP J van Enckevort, J H Zwaveling, J T Bottema, et al.Pharmacoeconomics|July 12, 2002
Ready-to-use injection preparations versus conventional reconstituted admixtures: economic evaluation in a real-life settingPhillipe van der Linden, Jacques Douchamps, Claude Schmitt, et al.Pharmacoeconomics|May 31, 2002
Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in CanadaDouglas Coyle, Andrew J Palmer, Robert TamPharmacoeconomics|July 27, 2002
On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerationsJohn M InadomiPharmacoeconomics|July 27, 2002
Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomesLisa L Ioannides-Demos, Joseph E Ibrahim, John J McNeilPharmacoeconomics|July 27, 2002
Direct medical cost of managing deep vein thrombosis according to the occurrence of complicationsJudith A O'Brien, Jaime J CaroPharmacoeconomics|September 10, 2003
Quality of life in patients with rheumatoid arthritis : which drugs might make a difference?Barbara Blumenauer, Ann Cranney, Jennifer Clinch, et al.Pageof 336